Clinical trial Recruiting at 1 site Observational Ages 18 to 65

Evaluating agitation in critically ill patients using remote video monitoring

Official title: A Multi-modal Recognition Model and Efficacy Evaluation for Agitation Behavior in Critically Ill Patients Based on Remote -Ultra-sensitive Detection Wave ---A Multi-center, Open-label, Observational Study

Run by Second Affiliated Hospital, Zhejiang University, School of Medicine · NCT06543602 · Data updated 2026-11-12

This study is testing a new way to use remote video monitoring to see if it can help doctors better manage agitation in critically ill patients in the ICU.

More Critically Ill trials

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment580 (estimated)
SponsorSecond Affiliated Hospital, Zhejiang University, School of Medicine
Academic / other
Locations2 sites (Hangzhou, Zhejiang and 1 other locations)
StatusRecruiting
StartedMay 1, 2024
Main results expectedApril 30, 2027
Study endsApril 30, 2027
Registry record updatedAugust 9, 2024
Trial IDNCT06543602 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are critically ill patients aged 18 to 65 who are at risk of agitation and have a RASS score of -2 or higher.

Probably not a fit

Patients who may not benefit from this study include those with pre-existing neurological or psychiatric conditions, terminal diseases, or those unable to provide consent.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the effectiveness of a multi-modal evaluation monitoring system for detecting agitation in critically ill patients. Participants who are already receiving this monitoring as part of their standard care will be observed over a period of three years. The study focuses on patients at risk of agitation in the ICU, utilizing remote video and ultra-sensitive detection technology to enhance patient care. The goal is to improve the management of agitation in this vulnerable population.

Why it matters

Potential benefit: If successful, this study could lead to improved monitoring and management of agitation in critically ill patients, enhancing their overall care and outcomes.

How similar studies have gone: While this approach is innovative, similar studies have shown promise in utilizing remote monitoring technologies for patient management, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients at risk of agitation in the ICU
* Patients with RASS score -2 and above
* ≦ 65 years old, ≧ 18 years old

Exclusion Criteria:

* The affected party refused to participate in this study
* Missing/incomplete information
* Vulnerable groups such as pregnant women, those who lack the capacity for civil conduct and do not have the consent of their legal representatives
* Maxillofacial trauma, burns, tumors, surgery, etc. affect facial expression
* Patients with limb impairment and amputation
* Spinal cord injury, limb movement/sensory limitations
* Patients with pre-existing neurological/psychiatric diseases
* Patients with malignant tumors
* Patients with infectious diseases
* Patients with terminal disease and dying disease
* Abnormal behavior due to head injury or craniocerebral disease

Where it's running

  • the second affiliated hospital, Zhejiang University school of medicine
    Hangzhou, Zhejiang, China
    Recruiting
  • Sahzu
    Hanzhou, Zhejiang, China
    Active not recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.